TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2015 DA - 2015// TI - Cancer statistics, 2015 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21254 DO - 10.3322/caac.21254 ID - Siegel2015 ER - TY - JOUR AU - Winter, J. M. PY - 2012 DA - 2012// TI - Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades JO - Ann Surg Oncol VL - 19 UR - https://doi.org/10.1245/s10434-011-1900-3 DO - 10.1245/s10434-011-1900-3 ID - Winter2012 ER - TY - JOUR AU - Fokas, E. PY - 2015 DA - 2015// TI - Pancreatic ductal adenocarcinoma: from genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic JO - Biochim Biophys Acta VL - 1855 ID - Fokas2015 ER - TY - JOUR AU - Erkan, M. PY - 2012 DA - 2012// TI - The role of stroma in pancreatic cancer: diagnostic and therapeutic implications JO - Nat Rev Gastroenterol Hepatol VL - 9 UR - https://doi.org/10.1038/nrgastro.2012.115 DO - 10.1038/nrgastro.2012.115 ID - Erkan2012 ER - TY - JOUR AU - Durymanov, M. O. AU - Rosenkranz, A. A. AU - Sobolev, A. S. PY - 2015 DA - 2015// TI - Current approaches for improving Intratumoral accumulation and distribution of nanomedicines JO - Theranostics VL - 5 UR - https://doi.org/10.7150/thno.11742 DO - 10.7150/thno.11742 ID - Durymanov2015 ER - TY - JOUR AU - Du, J. Z. PY - 2014 DA - 2014// TI - Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy JO - Biotechnol Adv VL - 32 UR - https://doi.org/10.1016/j.biotechadv.2013.08.002 DO - 10.1016/j.biotechadv.2013.08.002 ID - Du2014 ER - TY - JOUR AU - Muthu, M. S. PY - 2014 DA - 2014// TI - Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics JO - Theranostics VL - 4 UR - https://doi.org/10.7150/thno.8698 DO - 10.7150/thno.8698 ID - Muthu2014 ER - TY - JOUR AU - Yang, T. PY - 2016 DA - 2016// TI - Anti-tumor efficiency of lipid-coated cisplatin nanoparticles co-loaded with MicroRNA-375 JO - Theranostics VL - 6 UR - https://doi.org/10.7150/thno.13130 DO - 10.7150/thno.13130 ID - Yang2016 ER - TY - JOUR AU - Xing, L. PY - 2016 DA - 2016// TI - Ultrasound-mediated microbubble destruction (UMMD) facilitates the delivery of CA19-9 targeted and paclitaxel loaded mPEG-PLGA-PLL nanoparticles in pancreatic Cancer JO - Theranostics VL - 6 UR - https://doi.org/10.7150/thno.15164 DO - 10.7150/thno.15164 ID - Xing2016 ER - TY - JOUR AU - Bose, R. J. AU - Lee, S. H. AU - Park, H. PY - 2016 DA - 2016// TI - Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications JO - Biomater Res VL - 20 UR - https://doi.org/10.1186/s40824-016-0081-3 DO - 10.1186/s40824-016-0081-3 ID - Bose2016 ER - TY - JOUR AU - Bertrand, N. PY - 2014 DA - 2014// TI - Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology JO - Adv Drug Deliv Rev VL - 66 UR - https://doi.org/10.1016/j.addr.2013.11.009 DO - 10.1016/j.addr.2013.11.009 ID - Bertrand2014 ER - TY - JOUR AU - Dong, X. AU - Mumper, R. J. PY - 2010 DA - 2010// TI - Nanomedicinal strategies to treat multidrug-resistant tumors: current progress JO - Nanomedicine VL - 5 UR - https://doi.org/10.2217/nnm.10.35 DO - 10.2217/nnm.10.35 ID - Dong2010 ER - TY - JOUR AU - Hollis, C. P. PY - 2013 DA - 2013// TI - Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery JO - J Control Release VL - 172 UR - https://doi.org/10.1016/j.jconrel.2013.06.039 DO - 10.1016/j.jconrel.2013.06.039 ID - Hollis2013 ER - TY - JOUR AU - Okamura, Y. PY - 2007 DA - 2007// TI - Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide JO - Transfusion VL - 47 UR - https://doi.org/10.1111/j.1537-2995.2007.01265.x DO - 10.1111/j.1537-2995.2007.01265.x ID - Okamura2007 ER - TY - JOUR AU - Moghimi, S. M. AU - Hunter, A. C. AU - Murray, J. C. PY - 2001 DA - 2001// TI - Long-circulating and target-specific nanoparticles: theory to practice JO - Pharmacol Rev VL - 53 ID - Moghimi2001 ER - TY - JOUR AU - Danhier, F. PY - 2012 DA - 2012// TI - PLGA-based nanoparticles: an overview of biomedical applications JO - J Control Release VL - 161 UR - https://doi.org/10.1016/j.jconrel.2012.01.043 DO - 10.1016/j.jconrel.2012.01.043 ID - Danhier2012 ER - TY - JOUR AU - Dreau, D. PY - 2016 DA - 2016// TI - Mucin-1-antibody-conjugated mesoporous silica nanoparticles for selective breast Cancer detection in a Mucin-1 transgenic murine mouse model JO - J Biomed Nanotechnol VL - 12 UR - https://doi.org/10.1166/jbn.2016.2318 DO - 10.1166/jbn.2016.2318 ID - Dreau2016 ER - TY - JOUR AU - Cooper, A. B. PY - 2015 DA - 2015// TI - Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates? JO - J Gastrointest Surg VL - 19 UR - https://doi.org/10.1007/s11605-014-2620-3 DO - 10.1007/s11605-014-2620-3 ID - Cooper2015 ER - TY - JOUR AU - Von Hoff, D. D. AU - Goldstein, D. AU - Renschler, M. F. PY - 2014 DA - 2014// TI - Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer JO - N Engl J Med VL - 370 ID - Von Hoff2014 ER - TY - JOUR AU - Von Hoff, D. D. PY - 2011 DA - 2011// TI - Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.36.5742 DO - 10.1200/JCO.2011.36.5742 ID - Von Hoff2011 ER - TY - JOUR AU - Frese, K. K. PY - 2012 DA - 2012// TI - Nab-paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-11-0242 DO - 10.1158/2159-8290.CD-11-0242 ID - Frese2012 ER - TY - JOUR AU - He, L. AU - Orr, G. A. AU - Horwitz, S. B. PY - 2001 DA - 2001// TI - Novel molecules that interact with microtubules and have functional activity similar to Taxol JO - Drug Discov Today VL - 6 UR - https://doi.org/10.1016/S1359-6446(01)02038-4 DO - 10.1016/S1359-6446(01)02038-4 ID - He2001 ER - TY - JOUR AU - Herbst, R. S. AU - Khuri, F. R. PY - 2003 DA - 2003// TI - Mode of action of docetaxel - a basis for combination with novel anticancer agents JO - Cancer Treat Rev VL - 29 UR - https://doi.org/10.1016/S0305-7372(03)00097-5 DO - 10.1016/S0305-7372(03)00097-5 ID - Herbst2003 ER - TY - JOUR AU - Kolishetti, N. PY - 2010 DA - 2010// TI - Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.1011368107 DO - 10.1073/pnas.1011368107 ID - Kolishetti2010 ER - TY - JOUR AU - Hattrup, C. L. AU - Gendler, S. J. PY - 2008 DA - 2008// TI - Structure and function of the cell surface (tethered) mucins JO - Annu Rev Physiol VL - 70 UR - https://doi.org/10.1146/annurev.physiol.70.113006.100659 DO - 10.1146/annurev.physiol.70.113006.100659 ID - Hattrup2008 ER - TY - JOUR AU - Gendler, S. J. PY - 2001 DA - 2001// TI - MUC1, the renaissance molecule JO - J Mammary Gland Biol Neoplasia VL - 6 UR - https://doi.org/10.1023/A:1011379725811 DO - 10.1023/A:1011379725811 ID - Gendler2001 ER - TY - JOUR AU - Yolken, R. H. PY - 1992 DA - 1992// TI - Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis JO - J Clin Invest VL - 90 UR - https://doi.org/10.1172/JCI116078 DO - 10.1172/JCI116078 ID - Yolken1992 ER - TY - JOUR AU - Burdick, M. D. PY - 1997 DA - 1997// TI - Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.39.24198 DO - 10.1074/jbc.272.39.24198 ID - Burdick1997 ER - TY - JOUR AU - Patton, S. AU - Gendler, S. J. AU - Spicer, A. P. PY - 1995 DA - 1995// TI - The epithelial mucin, MUC1, of milk, mammary gland and other tissues JO - Biochim Biophys Acta VL - 1241 UR - https://doi.org/10.1016/0304-4157(95)00014-3 DO - 10.1016/0304-4157(95)00014-3 ID - Patton1995 ER - TY - JOUR AU - Roy, L. D. PY - 2011 DA - 2011// TI - MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2010.526 DO - 10.1038/onc.2010.526 ID - Roy2011 ER - TY - JOUR AU - Cheever, M. A. PY - 2009 DA - 2009// TI - The prioritization of Cancer antigens: a National Cancer Institute pilot project for the acceleration of translational research JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-0737 DO - 10.1158/1078-0432.CCR-09-0737 ID - Cheever2009 ER - TY - JOUR AU - Curry, J. M. PY - 2013 DA - 2013// TI - The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer JO - J Surg Oncol VL - 107 UR - https://doi.org/10.1002/jso.23316 DO - 10.1002/jso.23316 ID - Curry2013 ER - TY - JOUR AU - Moore, L. J. PY - 2016 DA - 2016// TI - Antibody-guided in vivo imaging for early detection of mammary gland tumors JO - Transl Oncol VL - 9 UR - https://doi.org/10.1016/j.tranon.2016.05.001 DO - 10.1016/j.tranon.2016.05.001 ID - Moore2016 ER - TY - JOUR AU - Wu, S. T. PY - 2018 DA - 2018// TI - Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004 JO - PLoS One VL - 13 UR - https://doi.org/10.1371/journal.pone.0193260 DO - 10.1371/journal.pone.0193260 ID - Wu2018 ER - TY - JOUR AU - Besmer, D. M. PY - 2011 DA - 2011// TI - Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-4439 DO - 10.1158/0008-5472.CAN-10-4439 ID - Besmer2011 ER - TY - JOUR AU - Sarin, V. K. PY - 1981 DA - 1981// TI - Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction JO - Anal Biochem VL - 117 UR - https://doi.org/10.1016/0003-2697(81)90704-1 DO - 10.1016/0003-2697(81)90704-1 ID - Sarin1981 ER - TY - JOUR AU - Farokhzad, O. C. PY - 2006 DA - 2006// TI - Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo JO - Proc Natl Acad Sci U S A VL - 103 UR - https://doi.org/10.1073/pnas.0601755103 DO - 10.1073/pnas.0601755103 ID - Farokhzad2006 ER - TY - JOUR AU - Zheng, C. PY - 2012 DA - 2012// TI - Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging JO - Biomaterials VL - 33 UR - https://doi.org/10.1016/j.biomaterials.2012.04.044 DO - 10.1016/j.biomaterials.2012.04.044 ID - Zheng2012 ER - TY - JOUR AU - Amin, M. L. AU - Kim, D. AU - Kim, S. PY - 2016 DA - 2016// TI - Development of hematin conjugated PLGA nanoparticle for selective cancer targeting JO - Eur J Pharm Sci VL - 91 UR - https://doi.org/10.1016/j.ejps.2016.05.029 DO - 10.1016/j.ejps.2016.05.029 ID - Amin2016 ER - TY - JOUR AU - Kamphorst, J. J. PY - 2015 DA - 2015// TI - Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-2211 DO - 10.1158/0008-5472.CAN-14-2211 ID - Kamphorst2015 ER - TY - JOUR AU - Sousa, C. M. AU - Kimmelman, A. C. PY - 2014 DA - 2014// TI - The complex landscape of pancreatic cancer metabolism JO - Carcinogenesis VL - 35 UR - https://doi.org/10.1093/carcin/bgu097 DO - 10.1093/carcin/bgu097 ID - Sousa2014 ER - TY - JOUR AU - Mahapatro, A. AU - Singh, D. K. PY - 2011 DA - 2011// TI - Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines JO - J Nanobiotechnology VL - 9 UR - https://doi.org/10.1186/1477-3155-9-55 DO - 10.1186/1477-3155-9-55 ID - Mahapatro2011 ER - TY - JOUR AU - Nobs, L. PY - 2004 DA - 2004// TI - Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting JO - Eur J Pharm Biopharm VL - 58 UR - https://doi.org/10.1016/j.ejpb.2004.04.006 DO - 10.1016/j.ejpb.2004.04.006 ID - Nobs2004 ER - TY - JOUR AU - Sadat Tabatabaei Mirakabad, F. PY - 2014 DA - 2014// TI - PLGA-based nanoparticles as cancer drug delivery systems JO - Asian Pac J Cancer Prev VL - 15 UR - https://doi.org/10.7314/APJCP.2014.15.2.517 DO - 10.7314/APJCP.2014.15.2.517 ID - Sadat Tabatabaei Mirakabad2014 ER - TY - JOUR AU - Guo, J. PY - 2011 DA - 2011// TI - Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery JO - Biomaterials VL - 32 UR - https://doi.org/10.1016/j.biomaterials.2011.07.004 DO - 10.1016/j.biomaterials.2011.07.004 ID - Guo2011 ER - TY - JOUR AU - Roy, L. D. PY - 2017 DA - 2017// TI - A tumor specific antibody to aid breast cancer screening in women with dense breast tissue JO - Genes Cancer VL - 8 ID - Roy2017 ER - TY - STD TI - Mukherjee P. Tumor specific antibodies and uses therefor. 2016, Google Patents. ID - ref47 ER - TY - JOUR AU - Zhou, R. PY - 2016 DA - 2016// TI - A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis JO - Oncogene VL - 35 UR - https://doi.org/10.1038/onc.2015.516 DO - 10.1038/onc.2015.516 ID - Zhou2016 ER - TY - STD TI - Steentoft C, et al. Glycan-directed car-t cells. Glycobiology. 2018; https://doi.org/10.1093/glycob/cwy00. ID - ref49 ER - TY - JOUR AU - Hisatsune, A. PY - 2009 DA - 2009// TI - Internalization of MUC1 by anti-MUC1 antibody from cell membrane through the macropinocytotic pathway JO - Biochem Biophys Res Commun VL - 388 UR - https://doi.org/10.1016/j.bbrc.2009.08.059 DO - 10.1016/j.bbrc.2009.08.059 ID - Hisatsune2009 ER - TY - JOUR AU - Fonseca, C. AU - Simões, S. AU - Gaspar, R. PY - 2002 DA - 2002// TI - Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity JO - J Control Release VL - 83 UR - https://doi.org/10.1016/S0168-3659(02)00212-2 DO - 10.1016/S0168-3659(02)00212-2 ID - Fonseca2002 ER -